26 Jul Ocugen
Posted at 21:42h
in
Abhi Gupta, Executive Vice President, Commercial and Business Development
Oct. 6 | 4:00pm | FLW Ballroom G
Malvern, PA
(NASDAQ: OCGN)
Ocugen is a pioneering biotechnology company focused on discovering, deveoping, and commercializing novel gene therapies to address major blindness diseases and offer hope for patients across the globe. We are making an impact on patients lives through courageous innovation–forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to address significant unmet medical need for large patient populations through our gene-agnostic approach.
